Fiche centre
National University Hospital
Singapore — Singapore
Essais liés10clinical trials
VilleSingaporelocalisation
PaysSingaporelocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07064473
Essais cliniques associés
10| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Giredestrant | Cancer | Phase 3 | NCT06065748 | A Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer) | ACTIVE_NOT_RECRUITING |
| Sotorasib | Cancer | Phase 3 | NCT05920356 | A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202) | RECRUITING |
| Vicadrostat | Hypertension | Phase 3 | NCT07064473 | EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease | RECRUITING |
| Histotripsie — HistoSonics Edison System | Cancer | Non applicable | NCT07428356 | HALT — Histotripsy for Ablation of Liver Tumours in Asia | RECRUITING |
| The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study | Alzheimer | Non applicable | NCT05007353 | The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) Study | COMPLETED |
| Emtricitabine (FTC) | Alzheimer | Phase 1 | NCT07210528 | SONATAS — Safety Of Nrtis for Alzheimer's Therapeutic Advancement in Singapore Study | ACTIVE_NOT_RECRUITING |
| Dose escalated, accelerated, hypofractionated radiotherapy | Cancer | Phase 2 | NCT00938418 | Hypofractionated Intensity Modulated Chemoradiotherapy to Treat Locally Advanced Non-Small Cell Lung Cancer | UNKNOWN |
| AZD9291 | Cancer | Phase 2 | NCT02811354 | Phase II Study of AZD9291 in Advanced Stage NSCLC With EGFR and T790M Mutations Detected in Plasma Ct-DNA | UNKNOWN |
| Sacituzumab govitecan-hziy | Cancer | Phase 3 | NCT06486441 | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) | ACTIVE_NOT_RECRUITING |
| pregabalin | Épilepsie | Phase 3 | NCT01262677 | Once-A-Day Pregabalin For Partial Seizures | COMPLETED |